United Bank (Virginia)’s Pfizer PFE Stock Holding History

United Bank (Virginia)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Sell	42,568 -53	-0.1%	-$1.39K	0.12%	77
2026 Q1	$1.2M	Buy	42,621 +125	+0.3%	+$3.33K	0.15%	67
2025 Q4	$1.06M	Buy	42,496 +3,386	+9%	+$85.4K	0.14%	71
2025 Q3	$997K	Sell	39,110 -3,043	-7%	-$75.1K	0.12%	72
2025 Q2	$1.02M	Sell	42,153 -9,921	-19%	-$231K	0.12%	72
2025 Q1	$1.32M	Sell	52,074 -411,585	-89%	-$10.8M	0.17%	65
2024 Q4	$12.3M	Sell	463,659 -1,460	-0.3%	-$39.6K	1.47%	28
2024 Q3	$13.5M	Buy	465,119 +13,945	+3%	+$407K	1.57%	28
2024 Q2	$12.6M	Buy	451,174 +560	+0.1%	+$15.4K	1.57%	25
2024 Q1	$12.5M	Buy	450,614 +66,863	+17%	+$1.86M	1.49%	30
2023 Q4	$11M	Buy	383,751 +10,931	+3%	+$330K	1.39%	31
2023 Q3	$12.4M	Buy	372,820 +22,071	+6%	+$780K	1.62%	24
2023 Q2	$12.9M	Buy	350,749 +50,660	+17%	+$1.97M	1.58%	27
2023 Q1	$12.2M	Buy	300,089 +231,078	+335%	+$9.98M	1.56%	28
2022 Q4	$3.54M	Sell	69,011 -6,218	-8%	-$298K	0.5%	37
2022 Q3	$3.29M	Sell	75,229 -1,983	-3%	-$96.4K	0.51%	37
2022 Q2	$4.05M	Buy	77,212 +1,932	+3%	+$98.5K	0.61%	34
2022 Q1	$3.9M	Sell	75,280 -2,021	-3%	-$105K	0.51%	35
2021 Q4	$4.56M	Sell	77,301 -483	-0.6%	-$23.9K	0.56%	34
2021 Q3	$3.35M	Sell	77,784 -3,747	-5%	-$166K	0.45%	40
2021 Q2	$3.19M	Buy	81,531 +1,315	+2%	+$51.1K	0.43%	40
2021 Q1	$2.91M	Sell	80,216 -2,032	-2%	-$72.1K	0.4%	42
2020 Q4	$3.03M	Sell	82,248 -6,287	-7%	-$231K	0.45%	39
2020 Q3	$3.08M	Sell	88,535 -3,336	-4%	-$117K	0.54%	32
2020 Q2	$2.85M	Sell	91,871 -221	-0.2%	-$7.51K	0.52%	34
2020 Q1	$2.85M	Sell	92,092 -2,888	-3%	-$98.4K	0.62%	33
2019 Q4	$3.53M	Sell	94,980 -1,524	-2%	-$54.3K	0.61%	36
2019 Q3	$3.29M	Buy	96,504 +4,254	+5%	+$155K	0.6%	35
2019 Q2	$3.79M	Sell	92,250 -6,378	-6%	-$253K	0.63%	37
2019 Q1	$3.97M	Buy	98,628 +34,751	+54%	+$1.39M	0.72%	31
2018 Q4	$2.65M	Buy	63,877 +22,442	+54%	+$932K	0.55%	37
2018 Q3	$1.73M	Sell	41,435 -79	-0.2%	-$3.04K	0.36%	44
2018 Q2	$1.43M	Sell	41,514 -1,209	-3%	-$41.3K	0.33%	42
2018 Q1	$1.44M	Sell	42,723 -3,966	-8%	-$136K	0.33%	44
2017 Q4	$1.6M	Buy	+46,689	New	+$1.59M	0.39%	44
2016 Q4	–	Sell	-16,334	Closed	-$525K	–	49
2016 Q3	$525K	Sell	16,334 -21,365	-57%	-$714K	0.56%	39
2016 Q2	$1.26M	Buy	37,699 +2,924	+8%	+$93.3K	1.24%	32
2016 Q1	$978K	Buy	+34,775	New	+$993K	0.98%	36

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

United Bank (Virginia)'s PFE Position: Q2 2026 in Review

United Bank (Virginia) reduced its Pfizer (PFE) stake by 0.12% in Q2 2026, selling an estimated $1.39K and leaving 42,568 shares worth $1.03M. The position accounts for 0.12% of the portfolio, ranked #77.

United Bank (Virginia) first reported a position in PFE in Q1 2016 and has held it in 38 quarters since. The position peaked at $13.5M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

United Bank (Virginia) held 42,568 shares of Pfizer worth $1.03M as of Q2 2026.
United Bank (Virginia) sold 53 Pfizer shares in Q2 2026, an estimated $1.39K.
Pfizer made up 0.12% of United Bank (Virginia)'s portfolio in Q2 2026, its #77 holding.
United Bank (Virginia) first reported a position in Pfizer in Q1 2016 and has held it in 38 quarters since.
United Bank (Virginia)'s Pfizer position peaked at $13.5M in Q3 2024.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on United Bank (Virginia)'s 13F filing for Q2 2026, filed 30 Jul 2026.